CYRXWのチャート
CYRXWの企業情報
| symbol | CYRXW |
|---|---|
| 会社名 | |
| 分野（sector） | Transportation ヘルスケア |
| 産業（industry） | Oil Refining/Marketing |
| 業種 | ― |
| 概要 | 事業概要 -- CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Brentwood, TN. |
| 本社所在地 | -- |
| 代表者氏名 | ― |
| 代表者役職名 | ― |
| 電話番号 | ― |
| 設立年月日 | -- |
| 市場名 | -- |
| ipoyear | ―年 |
| 従業員数 | - |
| url | ― |
| nasdaq_url | https://www.nasdaq.com/symbol/cyrxw |
| adr_tso | ― |
| EBITDA | EBITDA ー |
| 終値（lastsale） | 7.6 |
| 時価総額（marketcap） | 0 |
| 時価総額 | 時価総額 ― |
| 売上高 | 売上高 -- |
| 企業価値(EV) | 企業価値(EV) ー |
| 当期純利益 | 当期純利益 -- |
| 決算概要 | 決算概要 -- |
CYRXWのテクニカル分析
CYRXWのニュース
Cryoport Revenue Grows 47% for First Quarter 2020 2020/05/07 20:05:00 PR Newswire
NASHVILLE, Tenn., May 7, 2020 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) (NASDAQ: CYRXW) ("Cryoport"), a global leader in life sciences solutions, today announced financial results for the three-month period ended March 31, 2020. "We reported revenue of $9.8 million for the First…